Skip to content
OpenCapital
Get started

Cardinal Health CAH Pharmaceutical and Specialty Solutions — Goodwill

Other segment segments

Other Segments
$1.75B+49.3%
Cost of product sold
$0—

Similar metrics at other companies

Amneal Pharmaceuticals, Inc. logo
AMRXSpecialty — Goodwill
$366.31M0.0%
Baxter International logo
BAXPharmaceuticals — Goodwill
$569M+2.2%
Opko Health logo
OPKPharmaceutical — Goodwill
$318.83M—
Bausch + Lomb logo
BLCOPharmaceuticals — Goodwill
$731M+8.0%
Scansource logo
SCSCSpecialty Technology Solutions — Goodwill
$173.89M+9.3%
Calumet, Inc. logo
CLMTSpecialty Products And Solutions — Goodwill
$49.3M0.0%

Other financials

Income statement

See full
Revenue$60.9B+11.0%
Gross profit$2.5B+17.7%
Operating income$509.0M-30.3%
Net income$399.0M-21.1%
EPS (diluted)$1.69-19.5%

Balance sheet

See full
Cash & equivalents$3.9B+18.4%
Total debt$8.9B+16.1%
Total equity-$2.8B+3.9%
Total assets$56.7B+13.7%

Cash flow

See full
Operating cash flow$1.8B-37.6%
CapEx$146.0M+15.9%
Free cash flow$1.7B-40.0%

Valuation

See full
Market cap$54.98B+41.0%
Enterprise value$59.96B+38.3%
P/E35.4×+10.3×
P/S0.2×0.0×

Profitability

See full
Gross margin3.8%+0.2pp
Operating margin0.9%-0.1pp
Net margin0.6%-0.1pp
FCF margin1.7%+0.6pp

Returns & leverage

See full
Return on equity37.4%—
Debt / equity4.1×—
Current ratio0.9×0.0×

Where this comes from

Reported directly by Cardinal Health in its filing.

Tagged under the XBRL concept us-gaap:Goodwill.

The official record: Cardinal Health’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cardinal Health's pharmaceutical and specialty solutions — goodwill.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Cardinal Health's pharmaceutical and specialty solutions — goodwill?
Cardinal Health (CAH) reported pharmaceutical and specialty solutions — goodwill of $9.67B in Q1 2026.
How has Cardinal Health's pharmaceutical and specialty solutions — goodwill changed year-over-year?
Cardinal Health's pharmaceutical and specialty solutions — goodwill increased by 25.0% year-over-year, from $7.74B to $9.67B.
What does pharmaceutical and specialty solutions — goodwill mean?
Represents the excess of the purchase price over the fair value of identifiable net assets acquired in business combinations within the Pharmaceutical and Specialty Solutions segment. It reflects the value of intangible assets such as brand reputation, customer relationships, and market position that cannot be individually identified. This balance is subject to periodic impairment testing to ensure it remains supported by the segment's future cash flows.